These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2180270)

  • 21. Usefulness of childhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study.
    Bao W; Srinivasan SR; Wattigney WA; Bao W; Berenson GS
    Arch Intern Med; 1996 Jun; 156(12):1315-20. PubMed ID: 8651840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010.
    Kit BK; Carroll MD; Lacher DA; Sorlie PD; DeJesus JM; Ogden C
    JAMA; 2012 Aug; 308(6):591-600. PubMed ID: 22871871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in lipids and lipoproteins in US adults, 1988-2010.
    Carroll MD; Kit BK; Lacher DA; Shero ST; Mussolino ME
    JAMA; 2012 Oct; 308(15):1545-54. PubMed ID: 23073951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids).
    Elshazly MB; Martin SS; Blaha MJ; Joshi PH; Toth PP; McEvoy JW; Al-Hijji MA; Kulkarni KR; Kwiterovich PO; Blumenthal RS; Jones SR
    J Am Coll Cardiol; 2013 Nov; 62(21):1960-1965. PubMed ID: 23973689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population.
    Nantsupawat N; Booncharoen A; Wisetborisut A; Jiraporncharoen W; Pinyopornpanish K; Chutarattanakul L; Angkurawaranon C
    Lipids Health Dis; 2019 Jan; 18(1):28. PubMed ID: 30684968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
    Davidson M; Ma P; Stein EA; Gotto AM; Raza A; Chitra R; Hutchinson H
    Am J Cardiol; 2002 Feb; 89(3):268-75. PubMed ID: 11809427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications.
    Martin SS; Blaha MJ; Elshazly MB; Brinton EA; Toth PP; McEvoy JW; Joshi PH; Kulkarni KR; Mize PD; Kwiterovich PO; Defilippis AP; Blumenthal RS; Jones SR
    J Am Coll Cardiol; 2013 Aug; 62(8):732-9. PubMed ID: 23524048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey.
    Hickman TB; Briefel RR; Carroll MD; Rifkind BM; Cleeman JI; Maurer KR; Johnson CL
    Prev Med; 1998; 27(6):879-90. PubMed ID: 9922071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
    Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
    Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.